US Patent 11542506 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
Patent 11542506 was granted and assigned to Voyager Therapeutics on January, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Apr, 2023
Golden AI
Infobox
Edits on 7 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115425060
Date of Patent
January 3, 2023
0Patent Application Number
171430360
Date Filed
January 6, 2021
0Patent Citations
Patent Primary Examiner
Edits on 30 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 4 Jan, 2023
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+261 characters)
US Patent 11542506 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
Article
The present invention relates to small interfering RNA (siRNA) molecules against the SOD1 gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating amyotrophic lateral sclerosis (ALS) using the siRNA molecules and AAV vectors.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115425060
Date of Patent
January 3, 2023
0Patent Application Number
171430360
Date Filed
January 6, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11542506 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.